You Position: Home > Journal issue

Clinical Oncology and Cancer Research

Items 1-5 of 6
«Preious | of 2 |
1

Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy

Cancer Biology & Medicine, Volume 20, Issue 5,2023, Pages 369-384, doi:10.20892/j.issn.2095-3941.2023.0046

2

Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas

Cancer Biology & Medicine, Volume 20, Issue 5,2023, Pages 325-343, doi:10.20892/j.issn.2095-3941.2022.0761

3

Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance

Cancer Biology & Medicine, Volume 20, Issue 5,2023, Pages 385-400, doi:10.20892/j.issn.2095-3941.2023.0011

4

Expert opinion on translational research for advanced glioblastoma treatment

Cancer Biology & Medicine, Volume 20, Issue 5,2023, Pages 344-352, doi:10.20892/j.issn.2095-3941.2023.0012

5

Development of glioblastoma organoids and their applications in personalized therapy

Cancer Biology & Medicine, Volume 20, Issue 5,2023, Pages 353-368, doi:10.20892/j.issn.2095-3941.2023.0061

Items 1-5 of 6
«Preious | of 2 |
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn